Luye Pharma Group Ltd - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Luye Pharma Group Ltd are shown. This page is a free Sustainability analysis for Luye Pharma Group Ltd. Jump to the end of this webpage for potential risks for Luye Pharma Group Ltd based on industry, geography and marketcap.
Luye Pharma Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Luye Pharma Group Ltd | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Luye Pharma Group Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Luye Pharma Group Ltd report the average age of the workforce?
Sign up for free to unlockDoes Luye Pharma Group Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Luye Pharma Group Ltd offer flexible work?
Sign up for free to unlockDoes Luye Pharma Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Luye Pharma Group Ltd conduct supply chain audits?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Luye Pharma Group Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose water use targets?
Sign up for free to unlockDoes Luye Pharma Group Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Luye Pharma Group Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Luye Pharma Group Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Luye Pharma Group Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Luye Pharma Group Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Luye Pharma Group Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Luye Pharma Group Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose its waste policy?
Sign up for free to unlockDoes Luye Pharma Group Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose energy use targets?
Sign up for free to unlockDoes Luye Pharma Group Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Luye Pharma Group Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Luye Pharma Group Ltd
These potential risks are based on the size, segment and geographies of the company.
Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders, In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sailimai for the treatment of diarrhea; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.